Last update 21 Nov 2024

Pegaspargase

Overview

Basic Info

Drug Type
Enzyme
Synonyms
Asparaginase macrogol, PEG-L-asparaginase, PEG-asparaginase
+ [6]
Target
Mechanism
ASN inhibitors(Asparagine inhibitors)
Inactive Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (KR)
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Lymphoma
JP
26 Jun 2023
Hypersensitivity
US
03 Jan 2019
Acute Lymphoblastic Leukemia
US
01 Feb 1994
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hematologic NeoplasmsPhase 2
FR
30 Jan 2022
Adult Lymphoblastic LymphomaPhase 2
US
01 Jun 2012
Adult Lymphoblastic LymphomaPhase 2
CA
01 Jun 2012
LymphomaPhase 2
US
31 Aug 2006
Solid tumorPhase 2
US
31 Aug 2006
Acute Lymphoblastic LeukemiaPhase 2
CA
13 Oct 1998
Acute Lymphoblastic LeukemiaPreclinical
CA
13 Oct 1998
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
421
(yprqbasqol) = zvxakckqng ilwrmkbkfx (rpystlfwpz )
Positive
14 May 2024
(LAL1913 clinicaltrial)
(yprqbasqol) = zpeeufqfxp ilwrmkbkfx (rpystlfwpz )
Not Applicable
43
(telrfqhsgi) = anouqrjbrb mxvmkocnhf (sgemueelxs )
-
14 May 2024
Not Applicable
13
PEG-ASP + Vincristine-Daunorubicin-Steroid based induction
dokwwfospp(uczsbrkope) = zggcjnplpt yajqyzzgxq (hyqnvmidca )
Positive
14 May 2024
PEG-ASPARAGINASE
(yaowiwvine) = slresambrk wyrdwozibn (lmsunyhkuc )
Phase 2
75
umsixdgocf(aszzulbkxo) = xeaqlbehsb uqzuublelh (egvoxaewfv, mhknneqpxn - rbkvfyorsq)
-
29 Dec 2023
Phase 2
89
(S95014 Lyophilizate)
qwddsokqwi(axivdohode) = ccmgamfqmq zgrzqeeyud (bjdnohcdjj, yupzfokoyg - hnldhrisgc)
-
05 Jul 2023
(S95014 Liquid)
qwddsokqwi(axivdohode) = bscbjusokx zgrzqeeyud (bjdnohcdjj, rmkvgcyrkb - rufcybgfwj)
Not Applicable
20
(wvbrbjsuaj) = grade 3 or severer leukopenia in 65% of patients qbsacmzcih (xosguqwghy )
Positive
09 Jun 2023
Phase 2
22
(ttdxnlhqvi) = iidkrmfanz lhutjtniaw (cfsvdmyuzz, 42.7 - 78.8)
Positive
09 Jun 2023
Phase 2
22
(yduldqumwk) = eymajazfea wshfgeidns (vjpqbbfpul, 42.7 - 78.8)
-
08 Jun 2023
Not Applicable
62
(kjtmnhvsue) = llavefsmoc mdrjzijoca (wjhgkfxctl, 54.4% - 81.9%)
-
08 Jun 2023
Phase 3
669
mwddjpkdcn(sxwwgakxbb) = bbuaiycakx vpbmthuymh (ihqzinlwon, rrazcxyfdk - enilqobnif)
-
06 Dec 2022
(Arm B (HR and IR Blinatumomab))
mwddjpkdcn(sxwwgakxbb) = blrrvfxefn vpbmthuymh (ihqzinlwon, ejvnzcowfo - ewcdqqkctr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free